The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium
Open accessAbstract
Abstract —Oxidative stress in the myocardium may play an important role in the pathogenesis of congestive heart failure (HF). However, the cellular sources and mechanisms for the enhanced generation of reactive oxygen species (ROS) in the failing myocardium remain unknown. The amount of thiobarbituric acid reactive substances increased in the canine HF hearts subjected to rapid ventricular pacing for 4 weeks, and immunohistochemical staining of 4-hydroxy-2-nonenal ROS-induced lipid peroxides was detected in cardiac myocytes but not in interstitial cells of HF animals. The generation of superoxide anion was directly assessed in the submitochondrial fractions by use of electron spin resonance spectroscopy with spin trapping agent, 5,5′-dimethyl-1-pyrroline- N -oxide, in the presence of NADH and succinate as a substrate for NADH–ubiquinone oxidoreductase (complex I) and succinate–ubiquinone oxidoreductase (complex II), respectively. Superoxide production was increased 2.8-fold ( P <0.01) in HF, which was due to the functional block of electron transport at complex I. The enzymatic activity of complex I decreased in HF (274±13 versus 136±9 nmol · min −1 · mg −1 protein, P <0.01), which may thus have caused the functional uncoupling of the respiratory chain and the deleterious ROS production in HF mitochondria. The present study provided direct evidence for the involvement of ROS in the mitochondrial origin of HF myocytes, which might be responsible for both contractile dysfunction and structural damage to the myocardium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Stadtman, E. R. (1992) · Science · doi:10.1126/science.1355616 · Cited by 2,697
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
Turrens, J. F., & Boveris, A. (1980) · Biochemical Journal · doi:10.1042/bj1910421 · Cited by 1,601
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Cleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., & Schapira, A. H. V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00424-2 · Cited by 1,241
Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Turrens, J. F., Alexandre, A., & Lehninger, A. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90293-0 · Cited by 1,214
Mechanism of myocardial "stunning".
Bolli, R. (1990) · Circulation · doi:10.1161/01.cir.82.3.723 · Cited by 992
Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases
Linnane, A., Ozawa, T., Marzuki, S., & Tanaka, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92145-4 · Cited by 983
Cited by
Myocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,048
Bhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.010 · Cited by 1,655
Oxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618
Oxygen, oxidative stress, hypoxia, and heart failure
Giordano, F. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524408 · Cited by 1,496
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
Self-citation4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Self-citationMitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
Mitochondrial function as a therapeutic target in heart failure
Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.203 · Cited by 803
Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772
Ide, T., Tsutsui, H., Hayashidani, S., Kang, D., Suematsu, N., Nakamura, K.-I., Utsumi, H., Hamasaki, N., & Takeshita, A. (2001) · Circulation Research · doi:10.1161/01.res.88.5.529 · Cited by 731
Self-citationProtective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Mitochondrial Dysfunction in Cardiac Disease: Ischemia–Reperfusion, Aging, and Heart Failure
Lesnefsky, E. J., Moghaddas, S., Tandler, B., Kerner, J., & Hoppel, C. L. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1378 · Cited by 709
Metabolic remodelling in heart failure
Bertero, E., & Maack, C. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0044-6 · Cited by 706
Calcium Signaling and Reactive Oxygen Species in Mitochondria
Bertero, E., & Maack, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.310082 · Cited by 617
Role of Oxidative Stress in Myocardial Hypertrophy and Failure
Sawyer, D. B., Siwik, D. A., Xiao, L., Pimentel, D. R., Singh, K., & Colucci, W. S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1526 · Cited by 571
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
What Causes Sudden Death in Heart Failure?
Tomaselli, G. F., & Zipes, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000145047.14691.db · Cited by 566
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 534
Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.213116 · Cited by 506
Stowe, D. F., & Camara, A. K. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2331 · Cited by 471
Paradies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A., & Ruggiero, F. M. (2004) · Circulation Research · doi:10.1161/01.res.0000109416.56608.64 · Cited by 468
Mitochondrial Complex I Deficiency Increases Protein Acetylation and Accelerates Heart Failure
Karamanlidis, G., Lee, C. F., Garcia-Menendez, L., Kolwicz, S. C., Suthammarak, W., Gong, G., Sedensky, M. M., Morgan, P. G., Wang, W., & Tian, R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.07.002 · Cited by 468
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Hypoxic pulmonary vasoconstriction
Moudgil, R., Michelakis, E. D., & Archer, S. L. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00733.2004 · Cited by 454
Takimoto, E., Champion, H. C., Li, M., Ren, S., Rodriguez, E. R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K. L., Wang, Y., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521968 · Cited by 450
Mitochondrial transcription factor A (TFAM): Roles in maintenance of mtDNA and cellular functions
Kang, D., Kim, S. H., & Hamasaki, N. (2007) · Mitochondrion · doi:10.1016/j.mito.2006.11.017 · Cited by 446
Self-citationZhang, M., Brewer, A. C., Schröder, K., Santos, C. X. C., Grieve, D. J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009700107 · Cited by 445
Ide, T., Tsutsui, H., Kinugawa, S., Suematsu, N., Hayashidani, S., Ichikawa, K., Utsumi, H., Machida, Y., Egashira, K., & Takeshita, A. (2000) · Circulation Research · doi:10.1161/01.res.86.2.152 · Cited by 427
Self-citationSuematsu, N., Tsutsui, H., Wen, J., Kang, D., Ikeuchi, M., Ide, T., Hayashidani, S., Shiomi, T., Kubota, T., Hamasaki, N., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055318.09997.1f · Cited by 427
Self-citationDiabetic Cardiovascular Disease Induced by Oxidative Stress
Kayama, Y., Raaz, U., Jagger, A., Adam, M., Schellinger, I., Sakamoto, M., Suzuki, H., Toyama, K., Spin, J., & Tsao, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025234 · Cited by 407
Sorescu, D., & Griendling, K. K. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00717.x · Cited by 406
Münzel, T., Gori, T., Keaney, J. F., Maack, C., & Daiber, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv305 · Cited by 394
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn280 · Cited by 377
Self-citationNO/redox disequilibrium in the failing heart and cardiovascular system
Hare, J. M., & Stamler, J. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524459 · Cited by 360
Mechanisms of Altered Ca 2+ Handling in Heart Failure
Luo, M., & Anderson, M. E. (2013) · Circulation Research · doi:10.1161/circresaha.113.301651 · Cited by 357
Mitochondria as a Therapeutic Target in Heart Failure
Bayeva, M., Gheorghiade, M., & Ardehali, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 332
Pimentel, D. R., Amin, J. K., Xiao, L., Miller, T., Viereck, J., Oliver-Krasinski, J., Baliga, R., Wang, J., Siwik, D. A., Singh, K., et al. (2001) · Circulation Research · doi:10.1161/hh1701.096615 · Cited by 332
Heymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J.-L., Cohen-Tervaert, J. W., Drexler, H., Filippatos, G., Felix, S. B., Gullestad, L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 323
Kinugawa, S., Tsutsui, H., Hayashidani, S., Ide, T., Suematsu, N., Satoh, S., Utsumi, H., & Takeshita, A. (2000) · Circulation Research · doi:10.1161/01.res.87.5.392 · Cited by 323
Self-citationKohlhaas, M., Liu, T., Knopp, A., Zeller, T., Ong, M. F., Böhm, M., O'Rourke, B., & Maack, C. (2010) · Circulation · doi:10.1161/circulationaha.109.914911 · Cited by 322
KATP channel‐independent targets of diazoxide and 5‐hydroxydecanoate in the heart
Hanley, P. J., Mickel, M., Löffler, M., Brandt, U., & Daut, J. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.023960 · Cited by 320
“This basal rate of production of ROS is augmented in the presence of complex I and complex III inhibitors (Turrens, 1997; Ide et al. 1999), and during ischaemia (Becker et al. 1999).”
BackgroundMitochondrial reactive oxygen species production and elimination
Nickel, A., Kohlhaas, M., & Maack, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.011 · Cited by 317
Redox signaling in cardiac myocytes
Santos, C. X. C., Anilkumar, N., Zhang, M., Brewer, A. C., & Shah, A. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.003 · Cited by 317
Li, Y., Chen, B., Yang, X., Zhang, C., Jiao, Y., Li, P., Liu, Y., Li, Z., Qiao, B., Bond Lau, W., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.039262 · Cited by 314
Myocardial repair/remodelling following infarction: roles of local factors
Sun, Y. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn333 · Cited by 295
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Faria, A., & Persaud, S. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.013 · Cited by 295
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
Bonora, M., Wieckowski, M. R., Sinclair, D. A., Kroemer, G., Pinton, P., & Galluzzi, L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0074-0 · Cited by 294
Ikeuchi, M., Matsusaka, H., Kang, D., Matsushima, S., Ide, T., Kubota, T., Fujiwara, T., Hamasaki, N., Takeshita, A., Sunagawa, K., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.524835 · Cited by 274
Self-citationLipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis
SULIMAN, H., WELTYWOLF, K., CARRAWAY, M., TATRO, L., & PIANTADOSI, C. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.005 · Cited by 269
Mitochondria in cardiac hypertrophy and heart failure
Rosca, M. G., Tandler, B., & Hoppel, C. L. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.09.002 · Cited by 267
Matsushima, S., Ide, T., Yamato, M., Matsusaka, H., Hattori, F., Ikeuchi, M., Kubota, T., Sunagawa, K., Hasegawa, Y., Kurihara, T., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.582239 · Cited by 262
Self-citationSiwik, D. A., & Colucci, W. S. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011393.40674.13 · Cited by 259
Excitation-contraction coupling and mitochondrial energetics
Maack, C., & O'Rourke, B. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0666-z · Cited by 256
BRENNAN, J., SOUTHWORTH, R., MEDINA, R., DAVIDSON, S., DUCHEN, M., & SHATTOCK, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.019 · Cited by 242
HANLEY, P., & DAUT, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.002 · Cited by 218
Lu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., Li, J., Huang, Y., Zhang, P., Zhao, B., et al. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2940 · Cited by 215
Ikeda, M., Ide, T., Fujino, T., Arai, S., Saku, K., Kakino, T., Tyynismaa, H., Yamasaki, T., Yamada, K.-I., Kang, D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119687 · Cited by 152
“[3–7] Mitochondrial transcription factor A (TFAM), which was initially cloned as an mtDNA transcription factor, also plays an essential role in the maintenance of mtDNA and mitochondrial homeostasis.”
Self-citationDILISA, F., & BERNARDI, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.009 · Cited by 139
“[57] Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, et al.”
BackgroundMechanisms of Sudden Cardiac Death: Oxidants and Metabolism
Yang, K.-C., Kyle, J. W., Makielski, J. C., & Dudley, S. C. (2015) · Circulation Research · doi:10.1161/circresaha.116.304691 · Cited by 127
A Possible Site of Superoxide Generation in the Complex I Segment of Rat Heart Mitochondria
Ohnishi, S. T., Ohnishi, T., Muranaka, S., Fujita, H., Kimura, H., Uemura, K., Yoshida, K.-I., & Utsumi, K. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-4117-y · Cited by 123
Wohlgemuth, S. E., Calvani, R., & Marzetti, E. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.007 · Cited by 97
Baldus, S., Müllerleile, K., Chumley, P., Steven, D., Rudolph, V., Lund, G. K., Staude, H.-J., Stork, A., Köster, R., Kähler, J., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.07.010 · Cited by 63
The importance of mitochondrial DNA in aging and cancer
Desler, C., Marcker, M. L., Singh, K. K., & Rasmussen, L. J. (2011) · Journal of Aging Research · doi:10.4061/2011/407536 · Cited by 49
“Correspondingly, ROS production is low in mitochondria with a functional ETC and increased when especially the mtDNA encoded subunits of complex I and III are mutated [44, 45].”
BackgroundYue, X., Acun, A., & Zorlutuna, P. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.06.031 · Cited by 16
Metadata
- Authors
- Ide, T., Tsutsui, H., Kinugawa, S., Utsumi, H., Kang, D., Hattori, N., Uchida, K., Arimura, K.-I., Egashira, K., & Takeshita, A.
- Venue
- Circulation Research
- Published
- 1999-08-20
- Volume
- 85
- Issue
- 4
- Pages
- 357-363
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2141663828
- Cited by
- 700
- References
- 39
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.